3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
104
Neoplasms
13
Neoplasm Metastasis
8
Sarcoma
6
Pancreatic Neoplasms
6
Ovarian Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Melanoma
5
Leukemia, Myeloid, Acute
5
Colorectal Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Squamous Cell Carcinoma of Head and Neck
4
Prostatic Neoplasms
4
Lung Neoplasms
4
Liposarcoma
4
Multiple Myeloma
3
Head and Neck Neoplasms
3
Glioblastoma
3
Endometrial Neoplasms
3
Colonic Neoplasms
3
Breast Diseases
3
Brain Neoplasms
3
Triple Negative Breast Neoplasms
2
Recurrence
2
Neoplasm, Residual
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Inflammation
2
Estrogen Receptor-positive Breast Cancer
2
Esophageal Squamous Cell Carcinoma
2
Interventions
Tamoxifen
16
Radiotherapy
9
Anastrozole
8
Letrozole
7
Chemotherapy, Adjuvant
7
Specimen Handling
6
Radiation
5
Neoadjuvant Therapy
5
Mastectomy, Segmental
5
Biopsy
5
Sentinel Lymph Node Biopsy
4
Psychiatric Rehabilitation
4
Mass Spectrometry
4
Immunohistochemistry
4
Gene Expression Profiling
4
Early Intervention, Educational
4
Counseling
4
exemestane
3
afimoxifene
3
Surveys and Questionnaires
3
Surgical Procedures, Operative
3
Methods
3
Mastectomy
3
Magnetic Resonance Spectroscopy
3
Fatty Acids, Omega-3
3
Chromatography, High Pressure Liquid
3
pasireotide
2
Trastuzumab
2
Standard of Care
2
Soybean Proteins
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Carcinoma, Intraductal, Noninfiltrating
×
palbociclib
×
Clear all
NCT03535506
2025-09-26
WI223281
Georgetown University
Phase 2
Terminated
17 enrolled
9 charts